Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimizing Antidepressant Treatment by Genotype-dependent Adjustment of Medication According to the ABCB1 Gene

NCT02237937 is registered in ClinicalTrials.gov with HolsboerMaschmeyer NeuroChemie GmbH as lead sponsor.

NCT NCT02237937
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02237937 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimizing Antidepressant Treatment by Genotype-dependent Adjustment of Medication According to the ABCB1 Gene
Lead sponsor
HolsboerMaschmeyer NeuroChemie GmbH
Phase
Phase 4
Overall status
Unknown status
Start date
September 30, 2011
Completion date
December 31, 2014
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

major depression